Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Opening Monetary Information: Your Exhaustive Manual for Finding out about Individual budget - 2Fake new headlights rule steer Australian drivers astray
- 33 moms, 3 countries, 1 very familiar problem: Why child care costs still don't add up for families
- 4Select Your Definitive Pizza Decision
- 5Web designers for Independent ventures
- Kristin Cavallari was the teen queen bee of 'Laguna Beach.' Now she's a 'cringey' mom.
- Far-right AfD invited back to Munich Security Conference in 2026
- These 3 Nail-Free Finds Completely Transformed My Drab Bathroom
- China bans storing cremated remains in empty 'bone ash apartments'
- Which camera do you believe is great for first-time clients? !
- Well known SUVs With Low Energy Utilization In 2024 vote
- Israel faces widespread condemnation as NGO ban comes into effect
- Vote in favor of your Number one Kind of Gems
- Israeli Chief of Staff declares new border with Gaza Strip
